Abstract
Positron emission tomography (PET) is a powerful imaging technology that can visualize and measure metabolic processes in vivo and/or obtain unique information about drug candidates. The identification of new and improved molecular probes plays a critical role in PET, but its progress is somewhat limited due to the lack of efficient and simple labelling methods to modify biologically active small molecules and/or drugs. Current methods to radiofluorinate unactivated arenes are still relatively limited, especially in a simple and site-selective way. Here we disclose a method for constructing C–18F bonds through direct halide/18F conversion in electron-rich halo(hetero)arenes. [18F]F− is introduced into a broad spectrum of readily available aryl halide precursors in a site-selective manner under mild photoredox conditions. Notably, our direct 19F/18F exchange method enables rapid PET probe diversification through the preparation and evaluation of an [18F]-labelled O-methyl tyrosine library. This strategy also results in the high-yielding synthesis of the widely used PET agent l-[18F]FDOPA from a readily available l-FDOPA analogue.
Similar content being viewed by others
Data availability
All data generated or analysed during this study are included in this Article (and its Supplementary Information files). The PET imaging data of the animal study have been deposited to the public repository Zenodo61.
References
Ametamey, S. M., Honer, M. & Schubiger, P. A. Molecular imaging with PET. Chem. Rev. 108, 1501–1516 (2008).
Pike, V. W. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol. Sci. 30, 431–440 (2009).
Deng, X. Y. et al. Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N- and 15O-labeling reactions. Angew. Chem. Int. Ed. 58, 2580–2605 (2019).
Aldeghi, M., Malhotra, S., Selwood, D. L. & Chan, A. W. Two- and three-dimensional rings in drugs. Chem. Biol. Drug Des. 83, 450–461 (2014).
Taylor, R. D., MacCoss, M. & Lawson, A. D. Rings in drugs. J. Med. Chem. 57, 5845–5859 (2014).
Meanwell, N. A. Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design. J. Med. Chem. 61, 5822–5880 (2018).
Zhou, Y. et al. Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II–III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas. Chem. Rev. 116, 422–518 (2016).
Jacobson, O., Kiesewetter, D. O. & Chen, X. Y. Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug. Chem. 26, 1–18 (2015).
Preshlock, S., Tredwell, M. & Gouverneur, V. 18F-Labeling of arenes and heteroarenes for applications in positron emission tomography. Chem. Rev. 116, 719–766 (2016).
van der Born, D. et al. Fluorine-18 labelled building blocks for PET tracer synthesis. Chem. Soc. Rev. 46, 4709–4773 (2017).
Krishnan, H. S., Ma, L. L., Vasdev, N. & Liang, S. H. 18F-Labeling of sensitive biomolecules for positron emission tomography. Chem. Eur. J. 23, 15553–15577 (2017).
Ding, Y. S. et al. Synthesis of high specific activity 6-[18F]fluorodopamine for positron emission tomography studies of sympathetic nervous-tissue. J. Med. Chem. 34, 861–863 (1991).
Cai, L. S., Lu, S. Y. & Pike, V. W. Chemistry with [18F]fluoride ion. Eur. J. Org. Chem. 2008, 2853–2873 (2008).
Cole, E. L., Stewart, M. N., Littich, R., Hoareau, R. & Scott, P. J. H. Radiosyntheses using fluorine-18: the art and science of late stage fluorination. Curr. Top. Med. Chem. 14, 875–900 (2014).
Adams, D. J. & Clark, J. H. Nucleophilic routes to selectively fluorinated aromatics. Chem. Soc. Rev. 28, 225–231 (1999).
Brooks, A. F., Topczewski, J. J., Ichiishi, N., Sanford, M. S. & Scott, P. J. Late-stage [18F]fluorination: new solutions to old problems. Chem. Sci. 5, 4545–4553 (2014).
Lee, E. et al. A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging. Science 334, 639–642 (2011).
Lee, E., Hooker, J. M. & Ritter, T. Nickel-mediated oxidative fluorination for PET with aqueous [18F] fluoride. J. Am. Chem. Soc. 134, 17456–17458 (2012).
Tredwell, M. et al. A general copper-mediated nucleophilic 18F fluorination of arenes. Angew. Chem. Int. Ed. 53, 7751–7755 (2014).
Taylor, N. J. et al. Derisking the Cu-mediated 18F-fluorination of heterocyclic positron emission tomography radioligands. J. Am. Chem. Soc. 139, 8267–8276 (2017).
Guibbal, F. et al. Manual and automated Cu-mediated radiosynthesis of the PARP inhibitor [18F]olaparib. Nat. Protoc. 15, 1525–1541 (2020).
Chun, J. H., Lu, S. Y., Lee, Y. S. & Pike, V. W. Fast and high-yield microreactor syntheses of ortho-substituted [18F]fluoroarenes from reactions of [18F]fluoride ion with diaryliodonium salts.J. Org. Chem. 75, 3332–3338 (2010).
Ichiishi, N. et al. Copper-catalyzed [18F]fluorination of (mesityl)(aryl)iodonium salts. Org. Lett. 16, 3224–3227 (2014).
Mossine, A. V. et al. Synthesis of [18F]arenes via the copper-mediated [18F]fluorination of boronic acids. Org. Lett. 17, 5780–5783 (2015).
Makaravage, K. J., Brooks, A. F., Mossine, A. V., Sanford, M. S. & Scott, P. J. H. Copper-mediated radiofluorination of arylstannanes with [18F]KF. Org. Lett. 18, 5440–5443 (2016).
McCammant, M. S. et al. Cu-mediated C–H 18F-fluorination of electron-rich (hetero)arenes. Org. Lett. 19, 3939–3942 (2017).
Rotstein, B. H., Stephenson, N. A., Vasdev, N. & Liang, S. H. Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics. Nat. Commun. 5, 4365 (2014).
Liang, S. H., Wang, L., Stephenson, N. A., Rotstein, B. H. & Vasdev, N. Facile 18F labeling of non-activated arenes via a spirocyclic iodonium(III) ylide method and its application in the synthesis of the mGluR5 PET radiopharmaceutical [18F] FPEB. Nat. Protoc. 14, 1530–1545 (2019).
Gendron, T. et al. Ring-closing synthesis of dibenzothiophene sulfonium salts and their use as leaving groups for aromatic 18F-fluorination. J. Am. Chem. Soc. 140, 11125–11132 (2018).
Neumann, C. N., Hooker, J. M. & Ritter, T. Concerted nucleophilic aromatic substitution with 19F− and 18F−. Nature 534, 369–373 (2016).
Xu, P. et al. Site-selective late-stage aromatic [18F]fluorination via aryl sulfonium salts. Angew. Chem. Int. Ed. 59, 1956–1960 (2020).
Tay, N. E. S. et al. 19F- and 18F-arene deoxyfluorination via organic photoredox-catalysed polarity-reversed nucleophilic aromatic substitution. Nat. Catal. 3, 734–742 (2020).
Hoover, A. J. et al. A transmetalation reaction enables the synthesis of [18F]5-fluorouracil from [18F]fluoride for human PET imaging. Organometallics 35, 1008–1014 (2016).
Sharninghausen, L. S. et al. NHC-copper mediated ligand-directed radiofluorination of aryl halides. J. Am. Chem. Soc. 142, 7362–7367 (2020).
Fang, W. Y. et al. Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review. Eur. J. Med. Chem. 173, 117–153 (2019).
Langer, O. et al. Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nucl. Med. Biol. 30, 285–291 (2003).
Rokka, J. et al. 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical. J. Labelled Compd Radiopharm. 56, 385–391 (2013).
Chen, W. et al. Direct arene C–H fluorination with 18F− via organic photoredox catalysis. Science 364, 1170–1174 (2019).
Zweig, A., Hodgson, W. G. & Jura, W. H. The oxidation of methoxybenzenes. J. Am. Chem. Soc. 86, 4124–4129 (1964).
Blom, E., Karimi, F. & Langstrom, B. [18F]/19F exchange in fluorine containing compounds for potential use in 18F-labelling strategies. J. Labelled Compd Radiopharm. 52, 504–511 (2009).
Wagner, F. M., Ermert, J. & Coenen, H. H. Three-step, ‘one-pot’ radiosynthesis of 6-fluoro-3,4-dihydroxy-l-phenylalanine by isotopic exchange. J. Nucl. Med. 50, 1724–1729 (2009).
Weiss, P. S., Ermert, J., Melean, J. C., Schafer, D. & Coenen, H. H. Radiosynthesis of 4-[18F]fluoro-l-tryptophan by isotopic exchange on carbonyl-activated precursors. Bioorg. Med. Chem. 23, 5856–5869 (2015).
Tay, N. E. S. & Nicewicz, D. A. Cation radical accelerated nucleophilic aromatic substitution via organic photoredox catalysis. J. Am. Chem. Soc. 139, 16100–16104 (2017).
Holmberg-Douglas, N. & Nicewicz, D. A. Arene cyanation via cation-radical accelerated-nucleophilic aromatic substitution. Org. Lett. 21, 7114–7118 (2019).
Venditto, N. J. & Nicewicz, D. A. Cation radical-accelerated nucleophilic aromatic substitution for amination of alkoxyarenes. Org. Lett. 22, 4817–4822 (2020).
Shewchuk, L. et al. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. J. Med. Chem. 43, 133–138 (2000).
Werry, E. L. et al. Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders. Int. J. Mol. Sci. 20, 3161 (2019).
Wang, Q. & Holst, J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am. J. Cancer Res. 5, 1281–1294 (2015).
Qi, Y. Q., Liu, X. H., Li, J., Yao, H. Q. & Yuan, S. H. Fluorine-18 labeled amino acids for tumor PET/CT imaging. Oncotarget 8, 60581–60588 (2017).
Kuchar, M. & Mamat, C. Methods to increase the metabolic stability of 18F-radiotracers. Molecules 20, 16186–16220 (2015).
Lee, S. L. Radioactive iodine therapy. Curr. Opin. Endocrinol. Diabetes Obes. 19, 420–428 (2012).
Barth, R. F., Mi, P. & Yang, W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun. 38, 35 (2018).
Garnett, E. S., Firnau, G. & Nahmias, C. Dopamine visualized in the basal ganglia of living man. Nature 305, 137–138 (1983).
Pretze, M., Wängler, C. & Wängler, B. 6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses. BioMed. Res. Int. 2014, e674063 (2014).
Libert, L. C. et al. Production at the Curie level of no-carrier-added 6-18F-fluoro-l-DOPA. J. Nucl. Med. 54, 1154–1161 (2013).
Luurtsema, G. et al. Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-l-DOPA. EJNMMI Radiopharm. Chem. 1, 7 (2017).
Mossine, A. V. et al. Synthesis of high-molar-activity [18F]6-fluoro-l-DOPA suitable for human use via Cu-mediated fluorination of a BPin precursor. Nat. Protoc. 15, 1742–1759 (2020).
Orlovskaya, V., Fedorova, O., Kuznetsova, O. & Krasikova, R. Cu-mediated radiofluorination of aryl pinacolboronate esters: alcohols as solvents with application to 6-l-[18F]FDOPA synthesis. Eur. J. Org. Chem. 2020, 7079–7086 (2020).
Krasikova, R. N. Nucleophilic synthesis of 6-l-[18F]FDOPA. Is copper-mediated radiofluorination the answer? Molecules 25, 4365 (2020).
Luxen, A. et al. Production of 6-[18F]fluoro-l-DOPA and its metabolism in vivo—a critical-review. Int. J. Rad. Appl. Instrum. B 19, 149–158 (1992).
Chen, W. et al. Arene Radiofluorination Enabled by Photoredox-Mediated Halide Interconversion (Zenodo, 2021); https://doi.org/10.5281/zenodo.5220725
Acknowledgements
This work was supported in part by the National Institutes of Health (NIBIB) grants R01EB029451 (Z.L. and D.A.N.) and 5R01CA233904 (Z.L.), UNC LCCC pilot grant (Z.L. and D.A.N.), grant 1S10OD023611 (Z.L.) and the startup fund from UNC Department of Radiology, Biomedical Research Imaging Center, and UNC Lineberger Comprehensive Cancer Center (Z.L.). N.E.S.T. and V.A.P are grateful for NSF Graduate Research Fellowships. We thank G. T. Bida for assistance with cyclotron operation, X. Wu for NMR data collection and the University of North Carolina’s Department of Chemistry Mass Spectrometry Core Laboratory, especially D. Weatherspoon, for their assistance with mass spectrometry analysis.
Author information
Authors and Affiliations
Contributions
W.C. originated the halides/18F conversion project, prepared the substrates and 19F-standards and performed the radiolabelling reactions. H.W. conducted the animal imaging studies and performed PET imaging data collection and analysis. N.E.S.T. was involved in the discovery of the 19F/18F exchange reaction. V.A.P. and K.-P.L. assisted in the synthesis and analysis of substrates. T.Z. assisted in the animal studies. Z.W. contributed to the initial discussion. D.A.N. and Z.L. conceived and supervised the project and experiments. W.C., D.A.N. and Z.L. wrote the manuscript. N.E.S.T. and V.A.P. assisted in editing the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors Z.L., D.A.N. and W.C. have filed a WO patent (patent applicant, The University of North Carolina at Chapel Hill, USA; inventors, Z. Li, D. Nicewicz and W. Chen; patent no. WO 2020176804) related to the labelling methodology in this manuscript and is under review. The remaining authors declare no competing interests.
Additional information
Peer review information Nature Chemistry thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Information
Substrates and standards preparation, general experiment procedures, Supplementary Figs. 1–140, Tables 1–83 and NMR spectra.
Rights and permissions
About this article
Cite this article
Chen, W., Wang, H., Tay, N.E.S. et al. Arene radiofluorination enabled by photoredox-mediated halide interconversion. Nat. Chem. 14, 216–223 (2022). https://doi.org/10.1038/s41557-021-00835-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-021-00835-7
- Springer Nature Limited
This article is cited by
-
Radiochemistry for positron emission tomography
Nature Communications (2023)